Welcome to Prism!

Upload scholarly work, create communities, get citable links and more. To get the most out of Prism, log in with your NetID and check out our guide.

Published 2001 | Version v1.0.0
Journal Article Open

Thrombotic microangiopathy in the cancer patient


Thrombotic microangiopathy, manifesting as thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome, is a common complication in cancer patients. It shares the pathogenic microvascular occlusive lesion and many clinical manifestations as the classical TTP, but the spectrum of complications varies widely. Several subsets are seen, including a microangiopathic hemolyticanemia in advanced cancer, chemotherapeutic drug-associated microangiopathy and those with the transplant setting. The prognosis is not as favorable as in classical TTP. Anecdotal reports indicate that responses are seen with plasma exchange and with immunoadsorption.


original_citation: Kwaan, H. C., & Gordon, L. I. (2001). Thrombotic microangiopathy in the cancer patient. Acta Haematol, 106(1-2), 52-56. https://doi.org/10.1159/000046589


cv 293 thromb microangio in CA.pdf
Files (419.9 kB)
Name Size Download all
419.9 kB Preview Download

Additional details

March 30, 2023
March 30, 2023